GlaxoSmithKline reported GBP1.36B in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US USD 7.41B 84M
Almirall ALM:SM EUR 13.9M 14.3M
Amgen AMGN:US USD 2.54B 364M
Argen X Bv ARGX:BB USD -41240000 199.78M
AstraZeneca AZN:LN USD 2.29B 796M
Eli Lilly And LLY:US USD 2.04B 38.3M
Fresenius FRE:GR EUR 555M 191M
Fresenius Medical Care FME:GR EUR 390.62M 6.38M
Genmab GEN:DC DKK 662M 2.61B
Gilead Sciences GILD:US USD 2.52B 357M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Glaxosmithkline GSK:US GBP 1.6B 409.03M
Hikma Pharmaceutical HIK:LN USD 269M 18M
Lonza Group LONN:SW CHF 683M 36M
Merk MRK:US USD 4.89B 560M
Novartis NOVN:VX USD 3.86B 195M
Orion ORNBV:FH EUR 40.5M 204.1M
Pfizer PFE:US USD 7.38B 3.3B
Philips PHIA:NA EUR 357M 292M
Recordati REC:IM EUR 115.57M 45.74M
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Roche Holding ROG:VX 8.85B 3.26B
Sanofi SAN:FP EUR 2.75B 1.68B